DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,677 Cr | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr | ₹3,031 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4,677 Cr |
| Mar2024 | ₹2,002 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹3,385 Cr |
| Mar2021 | ₹3,031 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,677 Cr | 133.60 | |
| Mar2024 | ₹2,002 Cr | 48.60 | |
| Mar2023 | ₹1,347 Cr | -60.20 | |
| Mar2022 | ₹3,385 Cr | 11.67 | |
| Mar2021 | ₹3,031 Cr | - | |
Compare Total Debt of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,136.3 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| MANKIND PHARMA | ₹99,835.6 Cr | 1.5% | -6.4% | 1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.6% |
-3.8% |
-6.9% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses